HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 204 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $354,000 | -99.9% | 22,000 | 0.0% | 1.97% | +20.6% |
| Q4 2018 | $321,860,000 | +80365.0% | 22,000 | 0.0% | 1.63% | -6.0% |
| Q3 2018 | $400,000 | +7.8% | 22,000 | 0.0% | 1.74% | -27.3% |
| Q2 2018 | $371,000 | -13.9% | 22,000 | 0.0% | 2.39% | +18.5% |
| Q1 2018 | $431,000 | -3.4% | 22,000 | 0.0% | 2.02% | +7.2% |
| Q4 2017 | $446,000 | +16.8% | 22,000 | 0.0% | 1.88% | +20.7% |
| Q3 2017 | $382,000 | +35.5% | 22,000 | 0.0% | 1.56% | +15.5% |
| Q2 2017 | $282,000 | -1.1% | 22,000 | 0.0% | 1.35% | -2.0% |
| Q1 2017 | $285,000 | +31.3% | 22,000 | 0.0% | 1.38% | +56.3% |
| Q4 2016 | $217,000 | -18.4% | 22,000 | 0.0% | 0.88% | -10.4% |
| Q3 2016 | $266,000 | +40.0% | 22,000 | 0.0% | 0.98% | +36.4% |
| Q2 2016 | $190,000 | -8.7% | 22,000 | 0.0% | 0.72% | -32.0% |
| Q1 2016 | $208,000 | -45.4% | 22,000 | 0.0% | 1.06% | -82.4% |
| Q4 2015 | $381,000 | +29.2% | 22,000 | 0.0% | 6.04% | +271.2% |
| Q3 2015 | $295,000 | +8.9% | 22,000 | +83.3% | 1.63% | +78.1% |
| Q2 2015 | $271,000 | +58.5% | 12,000 | 0.0% | 0.91% | +75.4% |
| Q1 2015 | $171,000 | +47.4% | 12,000 | 0.0% | 0.52% | +727.0% |
| Q4 2014 | $116,000 | – | 12,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |